KYMR |
Kymera Therapeutics, Inc. |
Jun 18, 2024 |
1 |
$0 |
4 |
Jun 20, 2024 |
Director |
BPMC |
Blueprint Medicines Corp |
Jun 12, 2024 |
2 |
$0 |
4 |
Jun 14, 2024 |
Director |
SYRE |
Spyre Therapeutics, Inc. |
May 14, 2024 |
1 |
$0 |
4 |
May 16, 2024 |
Director |
BPMC |
Blueprint Medicines Corp |
Mar 20, 2024 |
9 |
-$2.01M |
4 |
Mar 22, 2024 |
Director |
BPMC |
Blueprint Medicines Corp |
Mar 7, 2024 |
1 |
-$1M |
4 |
Mar 26, 2024 |
Director |
KYMR |
Kymera Therapeutics, Inc. |
Feb 20, 2024 |
6 |
-$144K |
4 |
Feb 21, 2024 |
Director |
BPMC |
Blueprint Medicines Corp |
Jan 25, 2024 |
8 |
-$1.87M |
4 |
Jan 29, 2024 |
Director |
KYMR |
Kymera Therapeutics, Inc. |
Jan 23, 2024 |
3 |
-$197K |
4 |
Jan 23, 2024 |
Director |
BPMC |
Blueprint Medicines Corp |
Dec 11, 2023 |
3 |
-$215K |
4 |
Dec 13, 2023 |
Director |
BPMC |
Blueprint Medicines Corp |
Nov 30, 2023 |
3 |
-$173K |
4 |
Dec 4, 2023 |
Director |
BPMC |
Blueprint Medicines Corp |
Nov 24, 2023 |
4 |
-$985K |
4 |
Nov 28, 2023 |
Director |
SYRE |
Spyre Therapeutics, Inc. |
Nov 22, 2023 |
3 |
$0 |
4/A |
Dec 8, 2023 |
Director |
SYRE |
Spyre Therapeutics, Inc. |
Nov 22, 2023 |
0 |
$0 |
3/A |
Dec 8, 2023 |
Director |
BPMC |
Blueprint Medicines Corp |
Nov 1, 2023 |
10 |
-$241K |
4 |
Nov 3, 2023 |
Director |
BPMC |
Blueprint Medicines Corp |
Sep 27, 2023 |
8 |
-$1.2M |
4 |
Sep 29, 2023 |
Director |
BPMC |
Blueprint Medicines Corp |
Aug 24, 2023 |
6 |
-$1.2M |
4 |
Aug 28, 2023 |
Director |
BPMC |
Blueprint Medicines Corp |
Jun 21, 2023 |
2 |
$0 |
4 |
Jun 23, 2023 |
Director |
KYMR |
Kymera Therapeutics, Inc. |
Jun 15, 2023 |
1 |
$0 |
4 |
Jun 20, 2023 |
Director |
BPMC |
Blueprint Medicines Corp |
Mar 6, 2023 |
2 |
-$447K |
4 |
Mar 8, 2023 |
Director |
BPMC |
Blueprint Medicines Corp |
Dec 5, 2022 |
5 |
-$833K |
4 |
Dec 7, 2022 |
Director |
BPMC |
Blueprint Medicines Corp |
Aug 19, 2022 |
7 |
-$554K |
4 |
Aug 23, 2022 |
Director |
BPMC |
Blueprint Medicines Corp |
Aug 16, 2022 |
7 |
-$1.2M |
4 |
Aug 18, 2022 |
Director |
BPMC |
Blueprint Medicines Corp |
Aug 8, 2022 |
5 |
-$632K |
4 |
Aug 10, 2022 |
Director |
MGTA |
Magenta Therapeutics, Inc. |
Jun 28, 2022 |
1 |
$0 |
4 |
Jun 30, 2022 |
Director |
KYMR |
Kymera Therapeutics, Inc. |
Jun 15, 2022 |
1 |
$0 |
4 |
Jun 16, 2022 |
Director |
BPMC |
Blueprint Medicines Corp |
May 16, 2022 |
7 |
-$949K |
4 |
May 18, 2022 |
Director |
BPMC |
Blueprint Medicines Corp |
Apr 6, 2022 |
3 |
-$276K |
4 |
Apr 8, 2022 |
CEO AND PRESIDENT, Director |
BPMC |
Blueprint Medicines Corp |
Mar 3, 2022 |
10 |
-$1.69M |
4 |
Mar 8, 2022 |
CEO AND PRESIDENT, Director |
BPMC |
Blueprint Medicines Corp |
Mar 1, 2022 |
2 |
$0 |
4 |
Mar 3, 2022 |
CEO AND PRESIDENT, Director |
BPMC |
Blueprint Medicines Corp |
Nov 15, 2021 |
8 |
-$3.08M |
4 |
Nov 17, 2021 |
CEO and President, Director |
BPMC |
Blueprint Medicines Corp |
Nov 1, 2021 |
3 |
-$501K |
4 |
Nov 3, 2021 |
CEO and President, Director |
BPMC |
Blueprint Medicines Corp |
Aug 26, 2021 |
2 |
$29.9K |
4 |
Aug 30, 2021 |
CEO and President, Director |
BPMC |
Blueprint Medicines Corp |
Aug 19, 2021 |
6 |
-$2.04M |
4 |
Aug 23, 2021 |
CEO and President, Director |
KYMR |
Kymera Therapeutics, Inc. |
Jun 16, 2021 |
1 |
$0 |
4 |
Jun 17, 2021 |
Director |
MGTA |
Magenta Therapeutics, Inc. |
Jun 1, 2021 |
1 |
$0 |
4 |
Jun 3, 2021 |
Director |
BPMC |
Blueprint Medicines Corp |
May 12, 2021 |
7 |
-$2.04M |
4 |
May 14, 2021 |
CEO and President, Director |